On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases.
about
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets.T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor RegressionHeterologous expression of human costimulatory molecule B7-2 and construction of B7-2 immobilized polyhydroxyalkanoate nanoparticles for use as an immune activation agentA gene expression signature associated with survival in metastatic melanomaTargeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?Immunohistochemistry in melanocytic proliferative lesions.Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients.Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significanceInsights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma.Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.Microglia in gemistocytic astrocytomas.From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and Biology
P2860
Q27853331-717255BC-3BC6-4E66-AB77-2C180DCDAA57Q30425516-62CFCFFD-B732-4B6B-98CB-EFC00F5D4F44Q33315713-4DF438CF-6897-4466-80FF-575D5C17B582Q33816848-EC577390-6D53-4CE5-9779-F45A4FF1D658Q34357030-5EF93CE2-091B-4F1A-A802-7BCDB2B8A531Q35220047-0A2707D6-4631-4B41-978E-E6121AD40256Q35551133-B54BD035-AE02-4198-BBAA-BFA8CB99C21DQ35798186-649CF012-E4AC-48F8-A628-E7922B2DFFF7Q35939427-44FC66E0-8B3F-4449-8C09-23D1E4408D0AQ37242917-71F78481-7818-4315-9284-1BE375628EBEQ37287152-5CEA4604-760A-43B5-A243-97F223029B09Q37474050-0BFC63D4-1470-47A6-A5D6-0B03F5AA9BDAQ45201798-6BB67F3F-A45D-4527-A695-A26C2CD3B843Q48307917-D8864C89-B48F-4504-8AA3-A8316280AD42Q58553780-7B230645-86CA-40AD-93EA-C86017E1B6DE
P2860
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2003
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
On the biological relevance of ...... cells in melanoma metastases.
@en
On the biological relevance of ...... cells in melanoma metastases.
@nl
type
label
On the biological relevance of ...... cells in melanoma metastases.
@en
On the biological relevance of ...... cells in melanoma metastases.
@nl
prefLabel
On the biological relevance of ...... cells in melanoma metastases.
@en
On the biological relevance of ...... cells in melanoma metastases.
@nl
P2093
P2860
P356
P1476
On the biological relevance of ...... r cells in melanoma metastases
@en
P2093
A Håkansson
B Gustafsson
L Håkansson
L Krysander
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600703
P407
P577
2003-02-01T00:00:00Z